+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Injury Treatment Market by Product, Treatment Modalities, End User, Injury Type - Global Forecast to 2030- Product Image
Vascular Injury Treatment Market by Product, Treatment Modalities, End User, Injury Type - Global Forecast to 2030- Product Image
Sale

Vascular Injury Treatment Market by Product, Treatment Modalities, End User, Injury Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986092
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vascular injury treatment market is evolving rapidly as clinical innovation and global regulatory changes redefine standards of care for acute and chronic vascular trauma. Senior decision-makers seeking strategic opportunities in this dynamic landscape will benefit from actionable insights on technology adoption, supply chain resilience, and shifting care models.

Market Snapshot: Vascular Injury Treatment Market

The vascular injury treatment market grew from USD 24.45 billion in 2024 to USD 27.92 billion in 2025. It is expected to continue growing at a CAGR of 13.80%, reaching USD 53.12 billion by 2030. Robust demand is fueled by expanding adoption of minimally invasive solutions, advancements in device design, and increased investment in endovascular therapies. Stakeholders are responding to clinical needs for therapies that rapidly restore perfusion, minimize complications, and support both emergent and elective procedures. Resulting growth is observed across hospitals, ambulatory surgical centers, and specialty clinics globally, reflecting widespread emphasis on efficient, high-precision care.

Scope & Segmentation

This report provides comprehensive coverage of the vascular injury treatment sector, examining key segments and technologies adopted worldwide. The research offers detailed insights across product types, treatment approaches, end-user environments, regional markets, and leading industry participants.

  • Product Categories: Catheters (aspiration, balloon, delivery), embolic protection devices (distal filters, proximal occlusion), stents (bare metal, covered, drug eluting), thrombolytic drugs (streptokinase, tissue plasminogen activator, urokinase), and vascular grafts (biological, synthetic)
  • Treatment Modalities: Endovascular repair (aortic, carotid, peripheral stenting), open surgery, pharmacotherapy (anticoagulants, antiplatelet drugs, thrombolytics)
  • End Users: Ambulatory surgical centers, hospitals, specialty clinics
  • Injury Types: Arterial, capillary, microvascular, and venous injuries
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, & Africa (notably United Kingdom, Germany, France, Russia, Saudi Arabia, South Africa, others), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia and more)
  • Companies Profiled: Medtronic, Abbott, Boston Scientific, Johnson & Johnson, W. L. Gore & Associates, Terumo, B. Braun, BD, Teleflex, Edwards Lifesciences

Key Takeaways for Decision-Makers

  • Minimally invasive endovascular repair is increasingly favored, driven by improved imaging, catheter design, and bioresorbable technologies that reduce perioperative risk and accelerate recovery.
  • Integration of digital health, telemedicine, and wearable monitoring platforms is improving perioperative care and enabling earlier detection of complications, supporting value-based hospital models.
  • Regenerative medicine and new vascular graft solutions are beginning to influence long-term vessel health, with innovation targeting durability and enhanced tissue integration.
  • Strategic partnerships and acquisitions are reshaping the competitive landscape, with established firms leveraging clinical data and manufacturing scale, while nimble innovators focus on user-centric, rapid-deployment solutions.
  • Regional variability is significant: North America leads on technology uptake and hybrid surgical suites; Europe and the Middle East focus on harmonized regulation and specialty care; Asia-Pacific is characterized by expansive infrastructure growth and cost-sensitive procurement.

Impact of 2025 US Medical Device Tariffs

Upcoming US tariffs on medical devices and raw materials are already driving adjustments in procurement and manufacturing strategies throughout the vascular injury treatment market. Rising costs for imported catheters, stents, and drugs are prompting manufacturers to localize production, diversify supply chains, and pursue tariff exemptions. US hospitals and ambulatory surgical centers are recalibrating capital allocation, while device makers and providers seek value-based agreements to offset budget pressures. Engagement with regulators and trade groups is ongoing, aiming to clarify product classifications and mitigate price volatility. Continued adaptation will be required to ensure uninterrupted supply and sustained growth in a shifting policy environment.

Market Research Methodology & Data Sources

Findings in this report derive from a rigorous blend of primary interviews with interventional clinicians, procedural specialists, and procurement leads, combined with secondary research across peer-reviewed publications, regulatory disclosures, and market filings. Data are triangulated through validation against procedure volumes, device usage, and real-world import-export metrics. Strategic analysis utilizes competitive benchmarking and value chain mapping to deliver actionable intelligence for executives navigating the vascular injury treatment market.

Why This Report Matters

  • Enables evidence-based decisions by clearly mapping growth drivers and adoption barriers across all key product and regional segments.
  • Facilitates competitive positioning with segment-specific insights on technology trends, procurement strategies, and emerging partnership models.
  • Supports proactive risk management in the face of tariff changes and shifting regulatory expectations, equipping leaders to balance clinical excellence with economic resilience.

Conclusion

The vascular injury treatment market is transforming in response to changing clinical demands and economic pressures. This report supplies the strategic intelligence needed to pursue technology investments and partnerships aligned with long-term market leadership. Leaders equipped with these insights can confidently shape organizational priorities for sustainable growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vascular Injury Treatment Market, by Product
8.1. Introduction
8.2. Catheters
8.2.1. Aspiration Catheters
8.2.2. Balloon Catheters
8.2.3. Delivery Catheters
8.3. Embolic Protection Devices
8.3.1. Distal Filters
8.3.2. Proximal Occlusion Devices
8.4. Stents
8.4.1. Bare Metal Stents
8.4.2. Covered Stents
8.4.3. Drug Eluting Stents
8.5. Thrombolytic Drugs
8.5.1. Streptokinase
8.5.2. Tissue Plasminogen Activator
8.5.3. Urokinase
8.6. Vascular Grafts
8.6.1. Biological Grafts
8.6.2. Synthetic Grafts
9. Vascular Injury Treatment Market, by Treatment Modalities
9.1. Introduction
9.2. Endovascular Repair
9.2.1. Aortic Stenting
9.2.2. Carotid Stenting
9.2.3. Peripheral Stenting
9.3. Open Surgery
9.4. Pharmacotherapy
9.4.1. Anticoagulants
9.4.2. Antiplatelet Drugs
9.4.3. Thrombolytics
10. Vascular Injury Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Vascular Injury Treatment Market, by Injury Type
11.1. Introduction
11.2. Arterial Injury
11.3. Capillary Injury
11.4. Microvascular Injury
11.5. Venous Injury
12. Americas Vascular Injury Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Vascular Injury Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Vascular Injury Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Abbott Laboratories
15.3.3. Boston Scientific Corporation
15.3.4. Johnson & Johnson
15.3.5. W. L. Gore & Associates, Inc.
15.3.6. Terumo Corporation
15.3.7. B. Braun Melsungen AG
15.3.8. Becton, Dickinson and Company
15.3.9. Teleflex Incorporated
15.3.10. Edwards Lifesciences Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VASCULAR INJURY TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. VASCULAR INJURY TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. VASCULAR INJURY TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VASCULAR INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DELIVERY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DISTAL FILTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COVERED STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY STREPTOKINASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TISSUE PLASMINOGEN ACTIVATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY UROKINASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AORTIC STENTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAROTID STENTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PERIPHERAL STENTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANTIPLATELET DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIAL INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CAPILLARY INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY MICROVASCULAR INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY VENOUS INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 77. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 78. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 79. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 80. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 81. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 82. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 83. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 84. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 94. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 95. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 142. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 144. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 145. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 146. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 147. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 149. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 150. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 151. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 155. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 156. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 157. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 159. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 160. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 161. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 162. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 175. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 177. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 178. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 179. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 180. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 181. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 182. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 183. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 184. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 188. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 189. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 190. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 191. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 192. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 193. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 194. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 195. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 230. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 232. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 233. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 234. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 235. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 236. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 237. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 238. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 239. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 252. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 254. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 255. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 256. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 257. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 258. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 259. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 260. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 261. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 263. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 265. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 266. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 269. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 270. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 271. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 272. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 296. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 297. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 298. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 299. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 300. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 301. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 302. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 303. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 304. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 305. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 307. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 308. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 309. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 310. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 311. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2018-2030 (USD MILLION)
TABLE 312. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 313. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 314. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2018-2030 (USD MILLION)
TABLE 315. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 316. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 318. IS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vascular Injury Treatment market report include:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • W. L. Gore & Associates, Inc.
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 27.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 53.12 Billion
Compound Annual Growth Rate13.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Peripheral Vascular Devices Market Size, Share & Trends Analysis Report by Type, Application (Peripheral Arterial Disease (PAD), Aneurysms, Venous Diseases), End-use (Hospitals, Ambulatory Surgical Centers), Region, and Segment Forecasts, 2025-2030 - Product Image

Peripheral Vascular Devices Market Size, Share & Trends Analysis Report by Type, Application (Peripheral Arterial Disease (PAD), Aneurysms, Venous Diseases), End-use (Hospitals, Ambulatory Surgical Centers), Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
U.S. Peripheral Vascular Devices And Accessories Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Peripheral Vascular Devices And Accessories Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • United States
From
Interventional Cardiology and Peripheral Vascular Devices Market 2025-2033 - Product Image

Interventional Cardiology and Peripheral Vascular Devices Market 2025-2033

  • Report
  • 145 Pages
  • Global
From
Continuous Renal Replacement Therapy Market by Consumables, Machines, Modality, Vascular Access, End User - Global Forecast to 2030 - Product Image

Continuous Renal Replacement Therapy Market by Consumables, Machines, Modality, Vascular Access, End User - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic Flow Alteration Devices), Region - Forecast to 2029 - Product Image

Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic Flow Alteration Devices), Region - Forecast to 2029

  • Report
  • 325 Pages
  • Global
From

About the Vascular Injury Treatment Market

The Vascular Injury Treatment market within the context of Cardiovascular Devices is a rapidly growing sector of the medical device industry. It includes a variety of products and services designed to treat vascular injuries, such as endovascular stents, embolic protection devices, and vascular closure devices. These products are used to treat a variety of conditions, including peripheral artery disease, stroke, and aneurysms. The market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. Additionally, the rising geriatric population and the increasing awareness of vascular injury treatments are expected to drive the market growth. Some of the major companies in the Vascular Injury Treatment market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Johnson & Johnson, and Terumo Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.